Association between the MTHFR C677T polymorphism and gastric cancer susceptibility: A meta-analysis of 5,757 cases and 8,501 controls

Chen,Long; Lu,Ning; Zhang,Bai‑Hong; Weng,Li; Lu,Jun

doi:10.3892/ol.2015.3356

Association between the MTHFR C677T polymorphism and gastric cancer susceptibility: A meta-analysis of 5,757 cases and 8,501 controls

Authors:
- Long Chen
- Ning Lu
- Bai‑Hong Zhang
- Li Weng
- Jun Lu
View Affiliations

Affiliations: Department of Oncology, Lanzhou Military Command General Hospital of the People's Liberation Army, Lanzhou, Gansu 730050, P.R. China, Department of Oncology, Urumqi Military Command General Hospital of the People's Liberation Army, Urumqi, Xinjiang 830000, P.R. China
Published online on: June 10, 2015 https://doi.org/10.3892/ol.2015.3356
Pages: 1159-1165

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Current data regarding the association between the methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and the risk of developing gastric cancer are insufficient to draw definite conclusions. Therefore, the present meta‑analysis was conducted to achieve a more precise estimation of the association. MEDLINE, EMBASE and Wanfang database searches resulted in the identification of 28 eligible studies describing 5,757 cases and 8,501 controls. The strength of the association between the MTHFR C677T polymorphism and gastric cancer risk were evaluated using crude odds ratios (ORs), with 95% confidence intervals (CIs). The pooled ORs were determined using homozygous (TT vs. CC), heterozygous (CT vs. CC), dominant (TT+CT vs. CC) and recessive (TT vs. CC+CT) models. When all studies were pooled into the meta‑analysis, significant associations were identified between the MTHFR C677T polymorphism and the risk of gastric cancer (homozygous model: OR, 1.39; 95% CI, 1.20‑1.62; heterozygous model: OR, 1.18; 95% CI, 1.05‑1.32; dominant model: OR, 1.23; 95% CI, 1.10‑1.38; recessive model: OR, 1.26; 95% CI, 1.12‑1.42). Stratification of the data by ethnicity identified a statistically significantly elevated risk of gastric cancer in Asian MTHFR C677T polymorphism populations (homozygous model: OR, 1.64; 95% CI, 1.43‑1.90; heterozygous model: OR, 1.30; 95% CI, 1.16‑1.45; dominant model: OR, 1.39; 95% CI, 1.25‑1.54; recessive model: OR, 1.41; 95% CI, 1.25‑1.51), but not in Caucasian populations (homozygous model: OR, 1.15; 95% CI, 0.89‑1.48; heterozygous model: OR, 1.03; 95% CI, 0.84‑1.25; dominant model: OR, 1.05; 95% CI, 0.86‑1.28; recessive model: OR, 1.09; 95% CI, 0.91‑1.31). Following adjustment for heterogeneity, the current meta‑analysis demonstrated that the MTHFR C677T polymorphism was not associated with the risk of gastric cancer in Caucasian individuals. Furthermore, no evidence of publication bias was observed. Thus, the current meta‑analysis indicates that the MTHFR C677T allele may be a low‑penetrant risk factor for the development of gastric cancer in Asian populations.

View Figures

View References

1	Ahn DH, Rah H, Choi YK, et al: Association of the miR-146aC>G, miR-149T>C, miR-196a2T>C, and miR-499A>G polymorphisms with gastric cancer risk and survival in the Korean population. Mol Carcinog (Suppl 1). 52:E39–E51. 2013. View Article : Google Scholar
2	Persson C, Canedo P, Machado JC, El-Omar EM and Forman D: Polymorphisms in inflammatory response genes and their association with gastric cancer: A HuGE systematic review and meta-analyses. Am J Epidemiol. 173:259–270. 2011. View Article : Google Scholar : PubMed/NCBI
3	Zhang FF, Terry MB, Hou L, et al: Genetic polymorphisms in folate metabolism and the risk of stomach cancer. Cancer Epidemiol Biomarkers Prev. 16:115–121. 2007. View Article : Google Scholar : PubMed/NCBI
4	Warshauer ME, Silverman DT, Schottenfeld D and Pollack ES: Stomach and colorectal cancers in Puerto Rican-born residents of New York City. J Natl Cancer Inst. 76:591–595. 1986.PubMed/NCBI
5	Jacques PF, Bostom AG, Williams RR, et al: Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation. 93:7–9. 1996. View Article : Google Scholar : PubMed/NCBI
6	Mu LN, Cao W, Zhang ZF, et al: Polymorphisms of 5, 10-methylenetetralydrofolate reductase (MTHFR), fruit and vegetable intake, and the risk of stomach cancer. Biomarkers. 12:61–75. 2007. View Article : Google Scholar : PubMed/NCBI
7	Gao C, Wu J, Ding J, et al: Polymorphisms of methylenetetrahydrofolate reductase C677T and the risk of stomach cancer. Zhonghua Liu Xing Bing Xue Za Zhi. 23:289–292. 2002.(In Chinese). PubMed/NCBI
8	Miao X, Xing D, Tan W, Qi J, Lu W and Lin D: Susceptibility to gastric cardia adenocarcinoma and genetic polymorphisms in methylenetetrahydrofolate reductase in an at-risk Chinese population. Cancer Epidemiol Biomarkers Prev. 11:1454–1458. 2002.PubMed/NCBI
9	Bi J, Cai L and Zheng Z: Study on C667T gene polymorphism and susceptibility to gastric cancer. Chin J Public. 21:6612005.
10	Shen H, Newmann AS, Hu Z, et al: Methylenetetrahydrofolate reductase polymorphisms/haplotypes and risk of gastric cancer: A case-control analysis in China. Oncol Rep. 13:355–360. 2005.PubMed/NCBI
11	Boccia S, Gianfagna F, Persiani R, et al: Methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and susceptibility to gastric adenocarcinoma in an Italian population. Biomarkers. 12:635–644. 2007. View Article : Google Scholar : PubMed/NCBI
12	Götze T, Röcken C, Röhl FW, et al: Gene polymorphisms of folate metabolizing enzymes and the risk of gastric cancer. Cancer Lett. 251:228–236. 2007. View Article : Google Scholar : PubMed/NCBI
13	Graziano F, Kawakami K, Ruzzo A, et al: Methylenetetrahydrofolate reductase 677C/T gene polymorphism, gastric cancer susceptibility and genomic DNA hypomethylation in an at-risk Italian population. Int J Cancer. 118:628–632. 2006. View Article : Google Scholar : PubMed/NCBI
14	Sarbia M, Geddert H, Kiel S, et al: Methylenetetrahydrofolate reductase C677T polymorphism and risk of adenocarcinoma of the upper gastrointestinal tract. Scand J Gastroenterol. 40:109–111. 2005. View Article : Google Scholar : PubMed/NCBI
15	Li S, Ji M, He N and Lu Z: Application of microarray-based method for methylenetetrahydrofolate reductase (MTHFR) polymorphisms in the risk of gastric carcinoma in east China population. J Nanosci Nanotechnol. 7:3245–3249. 2007. View Article : Google Scholar : PubMed/NCBI
16	Wang Y, Guo W, He Y, et al: Association of MTHFR C677T and SHMT1 C1420T with susceptibility to ESCC and GCA in a high incident region of Northern China. Cancer Causes Control. 18:143–152. 2007. View Article : Google Scholar : PubMed/NCBI
17	Weng YR, Sun DF, Fang JY, Gu WQ and Zhu HY: Folate levels in mucosal tissue but not methylenetetrahydrofolate reductase polymorphisms are associated with gastric carcinogenesis. World J Gastroenterol. 12:7591–7597. 2006.PubMed/NCBI
18	Si PR, Fang DC, Zhang H, Yang LQ, Luo YH and Liao HY: The relationship between methylenetetrahydrofolate reductase gene polymorphism and microsatellite instability in gastric cancer. Zhonghua Liu Xing Bing Xue Za Zhi. 26:794–799. 2005.(In Chinese). PubMed/NCBI
19	Kim JK, Kim S, Han JH, et al: Polymorphisms of 5,10-methylenetetrahydrofolate reductase and risk of stomach cancer in a Korean population. Anticancer Res. 25:2249–2252. 2005.PubMed/NCBI
20	Wang LD, Guo RF, Fan ZM, et al: Association of methylenetetrahydrofolate reductase and thymidylate synthase promoter polymorphisms with genetic susceptibility to esophageal and cardia cancer in a Chinese high-risk population. Dis Esophagus. 18:177–184. 2005. View Article : Google Scholar : PubMed/NCBI
21	Stolzenberg-Solomon RZ, Qiao YL, Abnet CC, et al: Esophageal and gastric cardia cancer risk and folate- and vitamin B(12)-related polymorphisms in Linxian, China. Cancer Epidemiol Biomarkers Prev. 12:1222–1226. 2003.PubMed/NCBI
22	Galván-Portillo MV, Cantoral A, Oñate-Ocaña LF, et al: Gastric cancer in relation to the intake of nutrients involved in one-carbon metabolism among MTHFR 677 TT carriers. Eur J Nutr. 48:269–276. 2009. View Article : Google Scholar : PubMed/NCBI
23	Zúñiga-Noriega JR, Velazco-Campos Mdel R, Aguirre-Rodríguez A, et al: C677T polymorphism of the MTHFR gene and the risk of developing distal gastric cancer in a Mexican population. Rev Gastroenterol Mex. 72:355–358. 2007.(In Spanish). PubMed/NCBI
24	Lacasaña-Navarro M, Galván-Portillo M, Chen J, López-Cervantes M and López-Carrillo L: Methylenetetrahydrofolate reductase 677C>T polymorphism and gastric cancer susceptibility in Mexico. Eur J Cancer. 42:528–533. 2006. View Article : Google Scholar : PubMed/NCBI
25	Vollset SE, Igland J, Jenab M, et al: The association of gastric cancer risk with plasma folate, cobalamin, and methylenetetrahydrofolate reductase polymorphisms in the European Prospective Investigation into Cancer and Nutrition. Cancer Epidemiol Biomarkers Prev. 16:2416–2424. 2007. View Article : Google Scholar : PubMed/NCBI
26	Zeybek U, Yaylim I, Yilmaz H, et al: Methylenetetrahydrofolate reductase C677T polymorphism in patients with gastric and colorectal cancer. Cell Biochem Funct. 25:419–422. 2007. View Article : Google Scholar : PubMed/NCBI
27	De Re V, Cannizzaro R, Canzonieri V, et al: MTHFR polymorphisms in gastric cancer and in first-degree relatives of patients with gastric cancer. Tumour Biol. 31:23–32. 2010. View Article : Google Scholar : PubMed/NCBI
28	Gao S, Ding LH, Wang JW, Li CB and Wang ZY: Diet folate, DNA methylation and polymorphisms in methylenetetrahydrofolate reductase in association with the susceptibility to gastric cancer. Asian Pac J Cancer Prev. 14:299–302. 2013. View Article : Google Scholar : PubMed/NCBI
29	Saberi S, Zendehdel K, Jahangiri S, et al: Impact of methylenetetrahydrofolate reductase C677T polymorphism on the risk of gastric cancer and its interaction with Helicobacter pylori infection. Iran Biomed J. 16:179–184. 2012.PubMed/NCBI
30	Li S, Cai MJ, Hou P and He NY: Single nucleotide polymorphisms(C677T and A1298C) in methylenetetrahy-drofolate reductase gene and susceptibility to gastric carcinoma. J Southeast Univ. 25:321–324. 2006.
31	Yang XX, Li FX, Yi JP, Li X, Sun JZ and Hu NY: Impact of methylenetetrahydrofolate reductase C677T polymorphism on the risk of gastric cancer, colorectal cancer and lung cancer. Guangdong Med J. 31:2375–2378. 2010.
32	Gao CM, Wu JZ, Ding JH, et al: MTHFR C677T genotypes, lifestyle and the risk of stomach cancer. China J Cancer Prev Treat. 8:187–190. 2001.
33	Sagoo GS, Little J and Higgins JP: Human Genome Epidemiology Network: Systematic reviews of genetic association studies. PLoS Med. 6:e282009. View Article : Google Scholar : PubMed/NCBI
34	Cochran WG: The combination of estimates from different experiments. Biometrics. 10:101–129. 1954. View Article : Google Scholar
35	Mantel N and Haenszel W: Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 22:719–748. 1959.PubMed/NCBI
36	DerSimonian R and Laird N: Meta-analysis in clinical trials. Control Clin Trials. 7:177–188. 1986. View Article : Google Scholar : PubMed/NCBI
37	Egger M, Davey Smith G, Schneider M and Minder C: Bias in meta-analysis detected by a simple, graphical test. BMJ. 315:629–634. 1997. View Article : Google Scholar : PubMed/NCBI
38	Galbraith RF: A note on graphical presentation of estimated odds ratios from several clinical trials. Stat Med. 7:889–894. 1988. View Article : Google Scholar : PubMed/NCBI
39	Hirschhorn JN, Lohmueller K, Byrne E and Hirschhorn K: A comprehensive review of genetic association studies. Genet Med. 4:45–61. 2002. View Article : Google Scholar : PubMed/NCBI
40	Wacholder S, Chanock S, Garcia-Closas M, El Ghormli L and Rothman N: Assessing the probability that a positive report is false: An approach for molecular epidemiology studies. J Natl Cancer Inst. 96:434–442. 2004. View Article : Google Scholar : PubMed/NCBI
41	Thorlund K, Imberger G, Johnston BC, et al: Evolution of heterogeneity (I²) estimates and their 95% confidence intervals in large meta-analyses. PLoS One. 7:e394712012. View Article : Google Scholar : PubMed/NCBI